Trial Profile
Emergency Department Use of Nebulized Budesonide as an Adjunct to Standardized Therapy in Acutely Ill Adults With Refractory Asthma: a Randomized, Double-Blinded, Placebo-Controlled Trial.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Mar 2016
Price :
$35
*
At a glance
- Drugs Budesonide (Primary) ; Ipratropium bromide; Prednisone; Salbutamol
- Indications Acute asthma
- Focus Therapeutic Use
- 20 Jan 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 Dec 2008 Planned end date changed from 1 Dec 2008 to 1 Dec 2009 as reported by ClinicalTrials.gov.
- 12 Feb 2008 New trial record.